Israel - Hebrew - Ministry of Health

kamada ltd, israel - pegfilgrastim - תמיסה להזרקה - pegfilgrastim 10 mg/ml - pegfilgrastim

Israel - Hebrew - Ministry of Health

eli lilly israel ltd, israel - insulin (human) - תמיסה להזרקה - insulin (human) 100 iu/ml - insulin (human) - insulin (human) - diabetes mellitus.

Israel - Hebrew - Ministry of Health

eli lilly israel ltd, israel - insulin (human) - תמיסה להזרקה - insulin (human) 100 iu/ml - insulin (human) - insulin (human) - diabetes mellitus.

Israel - Hebrew - Ministry of Health

eli lilly israel ltd, israel - insulin (human) - תרחיף להזרקה - insulin (human) 100 iu/ml - insulin (human) - insulin (human) - diabetes melitus.

Israel - Hebrew - Ministry of Health

eli lilly israel ltd, israel - insulin (human) - תרחיף להזרקה - insulin (human) 100 iu/ml - insulin (human) - insulin (human) - diabetes melitus.

Israel - Hebrew - Ministry of Health

eli lilly israel ltd, israel - insulin (human) - תרחיף להזרקה - insulin (human) 100 iu/ml - insulin (human) - insulin (human) - for the treatment of diabetes.

Israel - Hebrew - Ministry of Health

eli lilly israel ltd, israel - insulin (human) - תרחיף להזרקה - insulin (human) 100 iu/ml - insulin (human) - insulin (human) - for the treatment of diabetes.

Israel - Hebrew - Ministry of Health

gilead sciences israel ltd - efavirenz; emtricitabine; tenofovir disoproxil as - טבליות מצופות פילם - tenofovir disoproxil as 245 mg; emtricitabine 200 mg; efavirenz 600 mg - tenofovir disoproxil - tenofovir disoproxil - atripla is indicated for use alone as a complete regimen or in combination with other antiretroviral agents for the treatment of hiv-1 infection in adults.

Israel - Hebrew - Ministry of Health

roche pharmaceuticals (israel) ltd - vemurafenib - טבליות מצופות פילם - vemurafenib 240 mg - vemurafenib - vemurafenib - zelboraf is indicated for the treatment of brafv600 mutation-positive unresectable or metastatic melanoma.

Israel - Hebrew - Ministry of Health

neopharm scientific ltd - lenalidomide - קפסולה קשיחה - lenalidomide 5 mg - lenalidomide - lenalidomide - 1. treatment of patients with transfusion-dependent anemia due to low- or intermediate - 1 - risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormality. 2. in combination with dexamethasone treatment of multiple myeloma patient who have received at least one prior therapy.